Design, synthesis, and evaluation of hinge-binder tethered 1,2,3-triazolylsalicylamide derivatives as Aurora kinase inhibitors

Bioorg Med Chem. 2016 May 1;24(9):2114-24. doi: 10.1016/j.bmc.2016.03.042. Epub 2016 Mar 25.

Abstract

A series of hinge-binder tethered 1,2,3-triazolylsalicylamide derivatives were designed, synthesized, and evaluated for the Aurora kinase inhibitory activities. The novel hinge-binder tethered 1,2,3-triazolylsalicylamide scaffold was effectively assembled by Cu(I)-catalyzed azide-alkyne 1,3-dipolar cycloaddition (CuAAC). A variety of alkynes with hinge binders were used to search proper structures-binding relationship to the hinge region. The synthesized 1,2,3-triazolylsalicylamide derivatives showed significant Aurora kinase inhibitory activity. In particular, 8a inhibited Aurora A kinase with an IC50 value of 0.284 μM, whereas 8m inhibited Aurora B kinase with an IC50 value of 0.364 μM.

Keywords: 1,2,3-Triazole; Anticancer; Aurora kinase; Click chemistry; Hinge-binder.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aurora Kinase A / antagonists & inhibitors*
  • Protein Kinase Inhibitors / pharmacology*
  • Salicylamides / pharmacology*

Substances

  • Protein Kinase Inhibitors
  • Salicylamides
  • Aurora Kinase A
  • salicylamide